A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)

Author： Raez Luis   Santos Edgardo   Webb R.   Wade James   Brito Roger   Karr Melissa   Kennah Andra   Childs Barrett  

Publisher： Springer Publishing Company

ISSN： 0344-5704

Source： Cancer Chemotherapy and Pharmacology, Vol.72, Iss.5, 2013-11, pp. : 1103-1110

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Phase II trial of weekly docetaxel and gemcitabine as first-line therapy for patients with advanced non-small cell lung cancer

By Kalmadi Sujith   McNeill Giles   Davis Mellar   Peereboom David   Adelstein David   Mekhail Tarek  

Medical Oncology, Vol. 23, Iss. 4, 2006-12 ,pp. : 507-513

Humana Press, Inc

Access to resources Recommend Favorite

Carboplatin and docetaxel in advanced non-small-cell lung cancer: results of a multicenter phase II study

By Ramalingam Sakkaraiappan   Dobbs Tracy   Einzig Avi   Wojtowicz-Praga Slawomir   Cascino Marianne   Bonomi Phillip   Belani Chandra  

Cancer Chemotherapy and Pharmacology, Vol. 53, Iss. 5, 2004-05 ,pp. : 439-444

Springer Publishing Company

Access to resources Recommend Favorite

Phase II study of S-1 and docetaxel for previously treated patients with locally advanced or metastatic non-small cell lung cancer

By Yanagihara Kazuhiro   Yoshimura Kenichi   Niimi Miyuki   Yasuda Hiroyasu   Sasaki Takahiko   Nishimura Takafumi   Ishiguro Hiroshi   Matsumoto Shigemi   Kitano Toshiyuki   Kanai Masashi   Misawa Akiko   Tada Harue   Teramukai Satoshi   Mio Tadashi   Fukushima Masanori  

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 5, 2010-10 ,pp. : 913-918

Springer Publishing Company

Access to resources Recommend Favorite

Systematic review and meta-analysis of randomised, phase II/III trials adding bevacizumab to platinum-based chemotherapy as first-line treatment in patients with advanced non-small-cell lung cancer

By  

Annals of Oncology, Vol. 24, Iss. 4, 2013-04 ,pp. : 1133-1133

Oxford University Press

Access to resources Recommend Favorite

Phase II study of weekly docetaxel combined with cisplatin in patients with advanced non-small-cell lung cancer

By Tsunoda Toshiyuki   Koizumi Tomonobu   Hayasaka Muneharu   Hirai Kazuya   Koyama Shigeru   Takabayashi Yasuki   Fujimoto Keisaku   Kubo Keishi  

Cancer Chemotherapy and Pharmacology, Vol. 54, Iss. 2, 2004-08 ,pp. : 173-177

Springer Publishing Company

Access to resources Recommend Favorite